Kalra, S., Aamir, A.H., Amin, M.F., Bajaj, S., Bulugahapitiya, U., Das, A.K., Ghosh, S., Gunatilake, S., Mahar, S.A., Qureshi, N., Raza, S.A., Shrestha, D., Somasundaram, N., Sumanatilleke, M. and Wijesinghe, A., 0AD. Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, {volume}({issue}), p.{page}.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

Kalra, S, et al.. “Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling”. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, vol. {volume}, no. {issue}, 0AD, p. {page}.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

Kalra, S., Aamir, A. H., Amin, M. F., Bajaj, S., Bulugahapitiya, U., Das, A. K., … Wijesinghe, A. (0AD). Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, {volume}({issue}), {page}.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

Kalra, S., A. H. Aamir, M. F. Amin, S. Bajaj, U. Bulugahapitiya, A. K. Das, S. Ghosh, et al.. 0AD. “Safe and Pragmatic Use of Sodium-glucose Co-transporter 2 (SGLT 2) Inhibitors: Medication Counseling”. Sri Lanka Journal of Diabetes Endocrinology and Metabolism {volume} ({issue}): {page}.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

1. Kalra S, Aamir AH, Amin MF, Bajaj S, Bulugahapitiya U, Das AK, et al.. Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling. Sri Lanka Journal of Diabetes Endocrinology and Metabolism. 0AD;{volume}({issue}):{page}. DOI: https://doi.org/10.4038/sjdem.v6i2.7316

1. Kalra S, Aamir AH, Amin MF, et al.. Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling. Sri Lanka Journal of Diabetes Endocrinology and Metabolism. 0AD;{volume}({issue}):{page}.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

Kalra S and others, ‘Safe and Pragmatic Use of Sodium-glucose Co-transporter 2 (SGLT 2) Inhibitors: Medication Counseling’ (0AD) {volume} Sri Lanka Journal of Diabetes Endocrinology and Metabolism {page}DOI: https://doi.org/10.4038/sjdem.v6i2.7316

[1]S. Kalra, “Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling”, Sri Lanka Journal of Diabetes Endocrinology and Metabolism, vol. {volume}, no. {issue}, p. {page}, 0AD.DOI: https://doi.org/10.4038/sjdem.v6i2.7316

Perspective

Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling

Authors:

Abstract

Keywords: